Loteprednol Etabonate                            
                            
                                An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions.
                                
                            
                                推出的年份: 2016(1990)                            
                                                                                        
                            
                            
                                                                树号: D04.210.500.054.079.129.284                            
                            
                                MeSH 单一 ID: D000069559                            
                                                                                        
                                    进入的组:
                                    
                                                                                    - Etabonate, Loteprednol
 
                                                                                    - CEHOAC
 
                                                                                    - Chloromethyl 17-ethoxycarbonyloxy-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate
 
                                                                                    - 17-ethoxycarbonyloxy-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate, Chloromethyl
 
                                                                                    - Chloromethyl 17 ethoxycarbonyloxy 11 hydroxy 3 oxoandrosta 1,4 diene 17 carboxylate
 
                                                                                    - Lotemax
 
                                                                                    - Loteprednol
 
                                                                                    - Alrex
 
                                                                            
                                 
                            
                                                        
                                                                                                                        
                                                                        
                                                            
                            
                            
                         
                                                                                                
留言 (0)